Development and in vitro evaluation of transdermal matrix films of metoprolol tartrate

Yakugaku Zasshi

Volumn 128, Issue 9, 2008, Pages 1325-1331

  Bhatt, Dinesh Chandra ^a   Dhake, Avinash Sridhar ^b   Khar, Roop Krishen ^c   Mishra, Dina Nath ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b LB Rao Institute of Pharmaceutical Education and Research   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Hypertension; Matrix film; Metoprolol tartrate; Porcine skin; Transdermal drug delivery

Indexed keywords

ETHYL CELLULOSE; METOPROLOL TARTRATE; PHTHALIC ACID DIBUTYL ESTER; POLYMER; POVIDONE;

ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; FILM; IN VITRO STUDY; PHYSICAL CHEMISTRY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; METOPROLOL; SKIN; SWINE;

EID: 50849131904     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1325     Document Type: Article

References (30)

1. Kevin Li S., Transdermal delivery technologies, in "Encyclopedia of Pharmaceutical Technology", III edition, ed. by Swarbrick J. Informa Healthcare USA, Inc., 2007, pp. 834-3853.
2. Williams A. C., Barry B. W., Adv. Drug Deliv. Rev., 56, 603-618 (2004).
3. Karande P., Jain A., Ergun K., Kispersky V., Mitragotri S., Proc. Natl. Acad. Sci. USA, 102, 4688-4793 (2005).
4. Singh P., Roberts M. S., J. Pharmacol. Exptl. Ther., 268, 144-151 (1994).
5. Hadgraft J., Lewis D., Beutner D., Wolff H. M., Int. J. Pharm., 73(2), 125-130 (1991).
6. Surber C., Wilhelm K. P., Hori M., Maibach H. I., Guy R. H., Pharm. Res., 7, 1320-1324 (1990).
7. Csoka G., Marton S., Otomo N., Antal I., Eur. J. Pharm. Biopharm., 65, 233-237 (2007).
8. Nair A., Ghosh B., Parcha V., Khanam J., Acta Pharm. Sci., 48, 179-193 (2006).
9. Kommuru T. R., Khan M. A., Reddy T. K., Chirality, 11(70), 536-540 (1999).
10. Aqil M., Sultana Y., Ali A., Dubey K., Najmi A. K., Pillai K. K., Drug Deliv., 11, 27-31 (2004).
11. Dick I., Scott R., J. Pharm. Pharmacol., 44, 640-645 (1982).
12. Schroeder I. J., Franke P., Schaefer U. F., Lehr C. M., J. Control. Rel., 118, 196-203 (2007).
13. Kanig J. L., Goodman H., J. Pharm. Sci., 51, 77-83 (1962).
14. The United States Pharmacopoeia, XXIII edition; US Pharmacopoeial Convention, Rockvile, 1999, pp. 1796-1799.
15. Franz T. J., J. Invest. Dermatol. 64(3), 190-195 (1975).
16. Andega S., Kanikkannan N., Singh M., J. Control. Rel., 77, 17-25 (2001).
17. Mosquera M. J., Cal S., Souto C., Concheiro A., Martinez-Pacheco R., Gomez-Amoz J. L., Drug Dev. Ind. Pharm., 23, 403-406 (1997).
18. Rao P. R., Diwan P. V., Drug Dev. Ind. Pharm., 24, 327-336 (1998).
19. Chien Y. W., Valia K. H., Drug Dev. Ind. Pharm., 10, 575-599 (1984).
20. Tojo K., Valia K. H., Chotani G., Chien Y. W., Drug Dev. Ind. Pharm., 11, 1175-1193 (1985).
21. Gupta R., Mukherjee B., Drug Dev. Ind. Pharm., 29(1), 1-7 (2003).
22. Costa P., Lobo J. M. S., Eur. J. Pharm. Sci., 13, 123-133 (2001).
23. Higuchi T., J. Pharm. Sci., 50, 874-875 (1961).
24. Higuchi T., J. Pharm. Sci., 52, 145-1149 (1963).
25. Giovangnoli A., Blasi P., Ricci M., Schoubben A., Perioli L., Rossi C., J. Pharm. Sci., 97 (1), 303-317 (2008).
26. Ritger P. L., Peppas N. A., J. Control. Rel., 5, 23-36 (1987).
27. Udaidulla U., Reddy M. V. S., Ruckmani K., Ahmad F. J., Khar R. K., AAPS PharmSciTech, Article 2, 8(1), E1-E8 (2007).
28. Miranda A., Millan M., Caraballo I., Int. J. Pharm., 311, 75-81 (2006).
29. Jamzad S., Tutunji L., Fassihi R., Int. J. Pharm., 292, 75-85 (2005).
30. Kalia Y. N., Guy R. H., Adv. Drug Deliv. Rev., 48, 159-172 (2001).